Steady states and oscillations in the p53/Mdm2 network

被引:186
|
作者
Ciliberto, A
Novak, B
Tyson, JJ
机构
[1] Hungarian Acad Sci, Mol Network Dynam Res Grp, Budapest, Hungary
[2] Budapest Univ Technol & Econ, Budapest, Hungary
[3] Virginia Polytech Inst & State Univ, Dept Biol, Blacksburg, VA 24061 USA
关键词
network dynamics; signal transduction; feedback control; tumor suppressors; p53;
D O I
10.4161/cc.4.3.1548
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
p53 is activated in response to events compromising the genetic integrity of a cell. Recent data show that p53 activity does not increase steadily with genetic damage but rather fluctuates in an oscillatory fashion. 7 Theoretical studies suggest that oscillations can arise from a combination of positive and negative feedbacks or from a long negative feedback loop alone. Both negative and positive feedbacks are present in the p53/Mdm2 network, but it is not known what roles they play in the oscillatory response to DNA damage. We developed a mathematical model of p53 oscillations based on positive and negative feedbacks in the p53/Mdm2 network. According to the model, the system reacts to DNA damage by moving from a stable steady state into a region of stable limit cycles. Oscillations in the model are born with large amplitude, which guarantees an all-or-none response to damage. As p53 oscillates, damage is repaired and the system moves back to a stable steady state with low p53 activity. The model reproduces experimental data in quantitative detail. We suggest new experiments for dissecting the contributions of negative and positive feedbacks to the generation of oscillations.
引用
收藏
页码:488 / 493
页数:6
相关论文
共 50 条
  • [11] Transcription factors that interact with p53 and Mdm2
    Inoue, Kazushi
    Fry, Elizabeth A.
    Frazier, Donna P.
    INTERNATIONAL JOURNAL OF CANCER, 2016, 138 (07) : 1577 - 1585
  • [12] Inhibition of p53 degradation by Mdm2 acetylation
    Wang, XJ
    Taplick, J
    Geva, N
    Oren, M
    FEBS LETTERS, 2004, 561 (1-3): : 195 - 201
  • [13] Mdm2 and MdmX partner to regulate p53
    Wang, Xinjiang
    Jiang, Xuejun
    FEBS LETTERS, 2012, 586 (10) : 1390 - 1396
  • [14] Mdm2: keeping p53 under control
    Jacques Piette
    Henry Neel
    Vincent Maréchal
    Oncogene, 1997, 15 : 1001 - 1010
  • [15] The p53 isoforms are differentially modified by Mdm2
    Camus, Suzanne
    Menendez, Sergio
    Fernandes, Kenneth
    Kua, Nelly
    Liu, Geng
    Xirodimas, Dimitris P.
    Lane, David P.
    Bourdon, Jean-Christophe
    CELL CYCLE, 2012, 11 (08) : 1646 - 1655
  • [16] Rapamycin increases the p53/MDM2 protein ratio and p53-dependent apoptosis by translational inhibition of mdm2 in cancer cells
    Kao, Chia-Li
    Hsu, Han-Shui
    Chen, Hsin-Wu
    Cheng, Tzu-Hao
    CANCER LETTERS, 2009, 286 (02) : 250 - 259
  • [17] The p53–Mdm2–HAUSP complex is involved in p53 stabilization by HAUSP
    C L Brooks
    M Li
    M Hu
    Y Shi
    W Gu
    Oncogene, 2007, 26 : 7262 - 7266
  • [18] A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas
    Rieske, P
    Bartkowiak, JK
    Szadowska, AM
    Olborski, B
    Harezga-Bal, B
    Debiec-Rychter, M
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 1999, 18 (03): : 403 - 416
  • [19] A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in liver cirrhosis and hepatocellular carcinoma
    Jablkowski, M
    Bocian, A
    Bialkowska, J
    Bartkowiak, J
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2005, 24 (01): : 117 - 125
  • [20] Ribosomal protein S7 as a novel modulator of p53–MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function
    D Chen
    Z Zhang
    M Li
    W Wang
    Y Li
    E R Rayburn
    D L Hill
    H Wang
    R Zhang
    Oncogene, 2007, 26 : 5029 - 5037